[1] Bach D.-H., Long N.P., Luu T.-T.-T. et al. The dominant role of forkhead box proteins in cancer[J]. International journal of molecular sciences, 2018, 19(10): 3279. [2] Laoukili J., Stahl M., Medema R.H. FoxM1: at the crossroads of ageing and cancer[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2007, 1775(1): 92-102. [3] 王思毓, 刘珊, 蒋永新. FOXM1 在结直肠癌中的作用及其机制[J]. 中国肿瘤生物治疗杂志, 2020, 27(5): 571-576. [4] Nandi D., Cheema P.S., Jaiswal N. et al. FoxM1: repurposing an oncogene as a biomarker[J]. Seminars in Cancer Biology, 2018, 52: 74-84. [5] Kim I.-M., Ackerson T., Ramakrishna S. et al. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer[J]. Cancer research, 2006, 66(4): 2153-2161. [6] Millour J., Constantinidou D., Stavropoulou A.V. et al. FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance[J]. Oncogene, 2010, 29(20): 2983-2995. [7] Halasi M., Gartel A.L. Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage[J]. PloS one, 2012, 7(2): e31761. [8] Yao Y., Wang X., Jiang L. et al. Prognostic and clinicopathological value of FOXM1 expression in colorectal cancer: a systematic review and meta-analysis[J]. Medicine, 2018, 97(52): e13899. [9] Zhang H., Xu X., Shi X. et al. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer[J]. Clinical and Translational Oncology, 2016, 18: 527-532. [10] Zhao H., Zhao C., Li H. et al. E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway[J]. Journal of Experimental & Clinical Cancer Research, 2019, 38(1): 1-11. [11] Yang C., Chen H., Yu L. et al. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer[J]. Cancer gene therapy, 2013, 20(2): 117-124. [12] Kopanja D., Chand V., O'Brien E. et al. Transcriptional repression by FoxM1 suppresses tumor differentiation and promotes metastasis of breast cancer[J]. Cancer Research, 2022, 82(13): 2458-2471. [13] Bektas N., Haaf A.t., Veeck J. et al. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer[J]. BMC cancer, 2008, 8: 1-9. [14] Network C.G.A.R. Integrated genomic analyses of ovarian carcinoma[J]. Nature, 2011, 474(7353): 609. [15] Liu C., Barger C.J., Karpf A.R. FOXM1: a multifunctional oncoprotein and emerging therapeutic target in ovarian cancer[J]. Cancers, 2021, 13(12): 3065. [16] Chen P.-M., Wu T.-C., Shieh S.-H. et al. MnSOD Promotes Tumor Invasion via Upregulation of FoxM1–MMP2 Axis and Related with Poor Survival and Relapse in Lung AdenocarcinomasMnSOD Promotes Lung Tumor Metastasis via FoxM1–MMP2 Axis[J]. Molecular Cancer Research, 2013, 11(3): 261-271. [17] Lu J., Wang Z., Cao J. et al. A novel and compact review on the role of oxidative stress in female reproduction[J]. Reproductive Biology and Endocrinology, 2018, 16: 1-18. [18] Xu Z., Pei C., Cheng H. et al. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma[J]. Frontiers in Immunology, 2023, 14: 1138524. [19] Shang R., Pu M., Li Y. et al. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression[J]. Oncology reports, 2017, 37(4): 2261-2269. [20] Xia L., Huang W., Tian D. et al. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma[J]. Journal of hepatology, 2012, 57(3): 600-612. [21] Li X., Qiu W., Liu B. et al. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel[J]. Journal of translational medicine, 2013, 11: 1-13. [22] Gu C., Yang Y., Sompallae R. et al. FOXM1 is a therapeutic target for high-risk multiple myeloma[J]. Leukemia, 2016, 30(4): 873-882. [23] Cheng Y., Sun F., Thornton K. et al. FOXM1 regulates glycolysis and energy production in multiple myeloma[J]. Oncogene, 2022, 41(32): 3899-3911. [24] DeCaprio J.A. Human papillomavirus type 16 E7 perturbs DREAM to promote cellular proliferation and mitotic gene expression[J]. Oncogene, 2014, 33(31): 4036-4038. [25] Guan P., Chen H., Li H.-J. et al. Expression and significance of FOXM1 in human cervical cancer: a tissue micro-array study[J]. Clinical and Investigative Medicine, 2011: E1-E7. [26] Chen H., Wang J., Yang H. et al. Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis[J]. Oncology letters, 2016, 12(4): 2664-2673. 作者简介：徐碧宇，女，汉族，1997 年 12 月，浙江台州，在读研究生，临床病理学。
